Yoshi Itoh

Associate Professor and Principal Investigator Cell Migration Group

After receiving his Msc in Pharmaceutical Sciences from Tokyo College of Pharmacy in Japan, in 1991 Dr Itoh moved to the University of Kansas Medical Center, USA to work with Prof Hideaki Nagase.

Using his research outcomes, he received a PhD from Tokyo University of Pharmacy and Life Sciences, Japan in 1996. In 1997 he became an Assistant Professor in Prof Motoharu Seiki's department at the Institute of Medical Sciences, University of Tokyo.

In 2001 he then moved to the Kennedy Institute of Rheumatology, Imperial College London to run his own lab and relocated to Oxford when the Kennedy Institute joined the University of Oxford.

His major scientific interests have been centred on mechanisms of cellular invasion and tissue destruction, especially in the aspects of arthritis and cancer as they share common mechanisms and pathways.

Recent publications

Prostate cancer-induced bone formation controlled by bone resorptive inflammatory cytokine IL-1.

Sugasaki M. et al, (2025), Biochem Biophys Res Commun, 792

Glutamine Promotes Myogenesis in Myoblasts Through Glutaminolysis-Mediated Histone H3 Acetylation That Enhances Myogenin Transcription.

Takatoya M. et al, (2025), Nutrients, 17

Microglial depletion increases aggrecan and hyaluronan levels in the diffuse and aggregated extracellular matrix of the mouse brain.

Egorova D. et al, (2025), Sci Rep, 15

The Diverse Pathways for Cell Surface MT1-MMP Localization in Migratory Cells.

Kelly H. et al, (2025), Cells, 14

Loss of ERα involved-HER2 induction mediated by the FOXO3a signaling pathway in fulvestrant-resistant breast cancer.

Karouji K. et al, (2025), Biochem Biophys Res Commun, 742

Cookies on this website

Contact information

Research groups